Matsumoto T, Kawanobe Y, Morita K, Ogata E
J Biol Chem. 1985 Nov 5;260(25):13704-9.
The effect of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) on phospholipid metabolism was examined in clonal rat osteogenic sarcoma cells, UMR 106, of osteoblastic phenotype. Treatment of UMR 106 cells with 10(-8)M 1,25-(OH)2D3 for 48 h caused an increase in [14C]serine incorporation into phosphatidylserine (PS) and a decrease in [3H]ethanolamine, [3H]linositol, and [14C]choline incorporation into phosphatidylethanolamine (PE), phosphatidylinositol, and phosphatidylcholine, respectively; the decrease in [3H]ethanolamine incorporation into PE was the largest. The total contents of phospholipids were similarly affected by 10(-8)M 1,25-(OH)2D3 treatment, suggesting that the effects of 1,25-(OH)2D3 are due largely to alterations in the synthesis of these phospholipids. The effects of 1,25-(OH)2D3 were evident at 10(-10) M 1,25-(OH)2D3, and 10(-8)M 1,25-(OH)2D3 caused a maximal stimulation of [14C]PS synthesis (167% of control) and a maximal reduction in the [3H]PE synthesis (41% of control). The [14C]PS/[3H]PE ratio increased gradually and reached a maximum after 70 h of treatment with 10(-8)M 1,25-(OH)2D3. When the cells were cultured in calcium-free medium containing 0.5 mM EGTA or when 5 microM cycloheximide was added to the medium, the effect of 1,25-(OH)2D3 on phospholipid metabolism was almost completely inhibited. Neither 25-hydroxyvitamin D3 nor 24,25-dihydroxyvitamin D3 caused significant changes in phospholipid metabolism. These results suggest that 1,25-(OH)2D3 alters phospholipid metabolism by enhancing PS synthesis through a calcium-dependent stimulation of the base exchange reaction of serine with other phospholipids and that the effect of 1,25-(OH)2D3 requires the synthesis of new proteins. Because PS is thought to be important for apatite formation and bone mineralization by binding calcium and phosphate to form calcium-PS-phosphate complexes, the present data suggest that 1,25-(OH)2D3 may stimulate bone mineralization by a direct effect on osteoblasts, stimulating PS synthesis.
在具有成骨细胞表型的克隆大鼠骨肉瘤细胞UMR 106中,研究了1,25 - 二羟基维生素D3(1,25-(OH)2D3)对磷脂代谢的影响。用10(-8)M 1,25-(OH)2D3处理UMR 106细胞48小时,导致[14C]丝氨酸掺入磷脂酰丝氨酸(PS)增加,而[3H]乙醇胺、[3H]肌醇和[14C]胆碱分别掺入磷脂酰乙醇胺(PE)、磷脂酰肌醇和磷脂酰胆碱减少;其中[3H]乙醇胺掺入PE的减少最为明显。10(-8)M 1,25-(OH)2D3处理同样影响了磷脂的总含量,这表明1,25-(OH)2D3的作用主要是由于这些磷脂合成的改变。1,25-(OH)2D3在10(-10) M时就有明显作用,10(-8)M 1,25-(OH)2D3对[14C]PS合成产生最大刺激(为对照的167%),对[3H]PE合成产生最大抑制(为对照的41%)。用10(-8)M 1,25-(OH)2D3处理70小时后,[14C]PS/[3H]PE比值逐渐升高并达到最大值。当细胞在含有0.5 mM EGTA的无钙培养基中培养或向培养基中加入5 microM放线菌酮时,1,25-(OH)2D3对磷脂代谢的影响几乎完全被抑制。25 - 羟基维生素D3和24,25 - 二羟基维生素D3均未引起磷脂代谢的显著变化。这些结果表明,1,25-(OH)2D3通过钙依赖性刺激丝氨酸与其他磷脂的碱基交换反应来增强PS合成,从而改变磷脂代谢,且1,25-(OH)2D3的作用需要新蛋白质的合成。由于PS被认为通过结合钙和磷酸盐形成钙 - PS - 磷酸盐复合物对磷灰石形成和骨矿化很重要,目前的数据表明1,25-(OH)2D3可能通过直接作用于成骨细胞,刺激PS合成来促进骨矿化。